MAP2K1 and Alzheimer disease: In AD brains, RAF‐1 shows increased phosphorylation at key sites (Ser338, Tyr340/341, and Ser259), which correlates with its activation and association with downstream MEK1/ERK signaling (Mei et al. 2006).